Zobrazeno 11 - 20
of 135
pro vyhledávání: '"Rin Yamaguchi"'
Autor:
Atsuko Masunaga, Akihito Abe, Rin Yamaguchi, Oi Harada, Hajime Kuroda, Akinari Kakumoto, Tsengelmaa Jamiyan
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background In this study, we investigated CD20+ TILs in triple-negative breast cancer (TNBC) and their relationship with T lymphocyte subsets (CD4+, CD8+, CD25+, and FOXP3+), including their combined prognostic value using an immunohistochemical stai
Autor:
Gábor Cserni, Edi Brogi, Hiram S. Cody, Rahul Deb, Gelareh Farshid, Sandra O'Toole, Elena Provenzano, Cecily M. Quinn, Aysegul A. Sahin, Fernando Schmitt, Donald L. Weaver, Rin Yamaguchi, Fleur Webster, Puay Hoon Tan
Publikováno v:
Archives of pathologylaboratory medicine. 146(11)
Context.— The International Collaboration on Cancer Reporting (ICCR), supported by major pathology and cancer organizations, aims at the standardization of evidence-based pathology reporting of different types of cancers, with the inclusion of all
Autor:
Isao Kitano, Kazumitsu Kiyomatsu, Ken Yamaguchi, Ryoko Egashira, Hiroyuki Irie, Takahiko Nakazono, Takahiro Hamamoto, Yukiko Hara, Fumio Yamasaki, Takeshi Imaizumi, Rin Yamaguchi
Publikováno v:
Breast Cancer. 28:572-580
Purpose of our study is to assess the relationship between MRI findings and invasive breast cancer (IBC) with cancer-associated fibroblasts (CAFs) that are positive for podoplanin. We retrospectively analyzed the consecutive 109 IBCs. The IBCs were d
Autor:
Hitoshi Obara, Hironori Kusano, Sachiko Ogasawara, Eiji Abe, Miki Yamaguchi, Hirohisa Yano, Rin Yamaguchi, Maki Tanaka, Jun Akiba, Yoshito Akagi, Momoko Akashi, Tatsuyuki Kakuma
Publikováno v:
Breast Cancer Research and Treatment. 184:277-285
Although HER2-positive (HER2+) invasive breast carcinomas (BC) have a different clinical therapeutic responsiveness according to estrogen and progesterone receptor expression, the relationship with androgen receptors (AR), which are the same family o
Publikováno v:
Virchows Archiv
Tumor-associated macrophages (TAMs) have recently been reported as an important factor in tumor growth and the progression of cancer. The prognostic significance of localizations and densities of TAMs in triple negative cancer (TNC) of the breast is
Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast
Autor:
Tsengelmaa Jamiyan, Masato Onozaki, Rin Yamaguchi, Yoshimasa Nakazato, Akihito Abe, Hajime Kuroda, Shuhei Noda, Mitsuhiro Hayashi
Publikováno v:
Breast Cancer (Tokyo, Japan)
BackgroundTumor-infiltrating lymphocytes (TILs) have recently been reported as an important factor in the tumor microenvironment and influence the growth and progression of cancer. However, the relationship between immune cell subpopulations, such as
Autor:
Reiki Nishimura, Hitomi Kawaji, Mai Yamada, Yurina Harada, Saori Hayashi, Kazuhisa Kaneshiro, Hitomi Mori, Masafumi Nakamura, Akiko Shimazaki, Masayuki Okido, Takafumi Morisaki, Makoto Kubo, Kanako Kurata, Rin Yamaguchi, Masaya Kai, Nobuyuki Arima
Publikováno v:
Cancer Research. 80:P1-10
[background] In general, TNBC has a high distant metastasis rate and is highly aggressive. Despite good response to chemotherapy, it has a poorer prognosis compared to other subtypes. There is a need to develop new treatments for the selection of app
Autor:
Momoko Akashi, Hitoshi Obara, Hirohisa Yano, Rin Yamaguchi, Jun Akiba, Uhi Toh, Maki Tanaka, Miki Yamaguchi, Tatsuyuki Kakuma, Yoshito Akagi, Hironori Kusano
Publikováno v:
Histopathology. 76:560-571
AIMS HER2-positive (HER2+) breast carcinoma (BC) cases are often treated similarly; however, they can be classified as either luminal B (LH) or non-luminal type (NLH) BC, which have different prognoses. In this study, we investigated the clinicohisto
Autor:
Fouzia Guestini, Yasuaki Sagara, Ayako Kanai, Yoshiaki Rai, Erina Iwabuchi, Maki Tanaka, Yasuhiro Miki, Takanori Ishida, Freeha Khalid, Hironobu Sasano, Rin Yamaguchi, Yasuyo Ohi, Keely May McNamara, Minoru Miyashita, Yoshiaki Onodera
Publikováno v:
Breast Cancer Research and Treatment. 180:97-110
Chemotherapy is the only current effective systemic treatment for triple-negative breast cancer (TNBC) patients. Therefore, the identification of active biological pathways that could become therapeutic targets is crucial. In this study, considering
Autor:
Satoshi Yamasaki, Yutaro Mihara, Gen Sugiyama, Munetoshi Nakashima, Naomi Yoshida, Suzuna Sugi, Daisuke Wakasugi, Kotaro Matsuda, Koichi Ohshima, Koki Satake, Hiroaki Ida, Rin Yamaguchi
Publikováno v:
Modern Rheumatology Case Reports. 4:161-167
A 70-year-old woman was hospitalised due to jaundice and fever. She was diagnosed with rheumatoid arthritis (RA) at 54 years of age. Treatment with methotrexate (MTX) was successful, and her RA was in remission. Five weeks before the hospitalisation,